دورية أكاديمية

In-Silico Evaluation of Tiryaq-E-Wabai, an Unani Formulation for its Potency against SARS-CoV-2 Spike Glycoprotein and Main Protease

التفاصيل البيبلوغرافية
العنوان: In-Silico Evaluation of Tiryaq-E-Wabai, an Unani Formulation for its Potency against SARS-CoV-2 Spike Glycoprotein and Main Protease
المؤلفون: AHMED, N ZAHEER, DAVIS, DICKY JOHN, ANWAR, NOMAN, KHAN, ASIM ALI, MEENA, RAM PRATAP, AFNAAN, ZEBA, DEVI, MEERA
المصدر: Journal of Drug Delivery and Therapeutics; Vol 11 No 4-S (2021): Volume 11, Issue 4-S, July-August 2021; 86-100 ; 2250-1177
بيانات النشر: Vinita Nagar, Society of Pharmaceutical Technocrats, 1/7756, Street no. 1, East Gorakh Park, Shahdara, Delhi, India 110032
سنة النشر: 2021
المجموعة: Journal of Drug Delivery and Therapeutics (JDDT)
الوصف: COVID-19 was originated in Wuhan, China, in December 2019 and has been declared a pandemic disease by WHO. The number of infected cases continues unabated and so far, no specific drug approved for targeted therapy. Hence, there is a need for drug discovery from traditional medicine. Tiryaq-e-Wabai is a well-documented formulation in Unani medicine for its wide use as prophylaxis during epidemics of cholera, plague and other earlier epidemic diseases. The objective of the current study is to generate in-silico evidence and evaluate the potency of Tiryaq-e-Wabai against SARS-CoV-2 spike (S) glycoprotein and main protease (3CLpro). The structures of all phytocompounds used in this study were retrieved from PubChem database and some were built using Marvin Sketch. The protein structure of the SARS-CoV-2 S glycoprotein and 3CLpro was retrieved from the PDB ID: 6LZG and 7BQY respectively. AutoDock Vina was used to predict top ranking poses with best scores. The results of the molecular docking showed that phytocompounds of Tiryaq-e-Wabai exhibited good docking power with spike glycoprotein and 3CLpro. Among tested compounds Crocin from Zafran and Aloin A from Sibr showed strong binding to spike glycoprotein and 3CLpro respectively. Molecular dynamics simulation confirmed the stability of the S glycoprotein-Crocin and 3CLpro-Aloin A complexes. The Unani formulation Tiryaq-e-Wabai has great potential to inhibit the SARS-CoV-2, which have to be substantiated with further in-vitro and in-vivo studies. Keywords: In-silico study, SARS-CoV-2, Tiryaq-e-Wabai, Unani formulation, Crocin, Aloin A
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf; text/html
اللغة: English
العلاقة: http://jddtonline.info/index.php/jddt/article/view/4993/4044Test; http://jddtonline.info/index.php/jddt/article/view/4993/4045Test; http://jddtonline.info/index.php/jddt/article/view/4993Test
DOI: 10.22270/jddt.v11i4-S.4993
الإتاحة: https://doi.org/10.22270/jddt.v11i4-S.4993Test
http://jddtonline.info/index.php/jddt/article/view/4993Test
حقوق: Copyright (c) 2021 N ZAHEER AHMED, DICKY JOHN DAVIS, NOMAN ANWAR, ASIM ALI KHAN, RAM PRATAP MEENA, ZEBA AFNAAN, MEERA DEVI ; http://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.13CD28F3
قاعدة البيانات: BASE